Mumbai, Aug. 18 -- Biocon's subsidiary in the United States has received supplemental U.S. Food and Drug Administration (FDA) approval for Yesintek(R) 45 mg/0.5 ml single-dose prefilled autoinjector and Yesintek(R) 90 mg/ml single-dose prefilled autoinjector.

Published by HT Digital Content Services with permission from Capital Market....